3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Rectal Neoplasms
11
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Nasopharyngeal Carcinoma
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Neoplasms
2
Adenocarcinoma
2
Pathologic Complete Response
1
Overall Survival Comparison Between the 2 Arms
1
Oropharyngeal Neoplasms
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Margins of Excision
1
Lymphatic Metastasis
1
Locally Advanced Malignant Neoplasm
1
Laryngeal Neoplasms
1
Laryngeal Diseases
1
Head and Neck Neoplasms
1
HPV-Related Squamous Cell Carcinoma
1
Glioblastoma
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Adenosquamous
1
Breast Neoplasms
1
Anus Neoplasms
1
Anal Canal Carcinoma
1
Interventions
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Overall Survival Comparison Between the 2 Arms
×
Chemoradiotherapy
×
Clear all
NCT02848716
2021-11-17
LiLACs
Institut Claudius Regaud
Phase 3
Withdrawn